Press releases

Read more:

Search
Categories

2025

Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media...
2025-07-10 08:10 Interim Report Q2 2025 Nanologica AB (publ) Regulatory
FINANCIAL SUMMARY EVENTS DURING THE SECOND QUARTER CEO COMMENTAs expected, the second quarter was not as strong in terms of sales as the first. However...
The number of registered shares and votes in Nanologica AB has changed during the month of June following the registration of exercised warrants of series...
The Board of Directors of Nanologica AB (publ) ("Nanologica" or the "Company") unanimously recommends the shareholders of Nanologica...
Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new customer in the US. The customer is a...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE...
Nanologica AB's (publ) ("Nanologica") main owner Flerie Invest AB ("Flerie") has today, May 23, 2025, made a mandatory cash offer...
Nanologica AB (publ) today May 22, 2025 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the...
Nanologica's main owner Flerie Invest AB ("Flerie") has acquired additional shares in Nanologica AB with the result that a mandatory bid...
Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new customer in China. The customer is a...